Highlights
A collection of news and information related to Human Genome Sciences Inc. published by this site and its partners.
Displaying items 1-12 of 21
» View ivpressonline.com items only
1
2
•
Next >
-
As top court invalidates some gene patents, biotech has moved on
ReutersNEW YORK (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech...Tags: Abbott Laboratories, Chemical Industry, Xalkori (drug), U.S. Supreme Court, Science
-
Letters: More on bioterrorism
Re "Raising an alarm — and his income," May 19 Your article alleging that I didn't adequately reveal a conflict of interest doesn't mention that the "About the Author" page of my 2003 bioterrorism report explicitly stated that I was "a director of...Tags: Anthrax, Bioterrorism, Science and Technology
-
Glaxo anti-cancer cocktail gets regulatory approval
The Baltimore SunAfter her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...Tags: McCormick Place, Health Organizations, Skin Cancer, American Cancer Society, Rockville (Bethlehem, Pennsylvania)
-
Bioterrorism consultant's anthrax claims challenged
WASHINGTON — As an example of the ease with which terrorists could produce anthrax, former Navy Secretary Richard J. Danzig has repeatedly cited the Japanese cult Aum Shinrikyo. The cult gained infamy in 1995 by unleashing the nerve agent sarin in...
Tags: Terrorism, George W. Bush, U.S. Department of Homeland Security, Biological and Chemical Weapons, Stranger Than Fiction
-
Pointing to threat, pulling in profit
Tribune Washington BureauWASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...Tags: U.S. Department of Defense, Michael Chertoff, U.S. Department of Homeland Security, Science, Finance
-
Spotlighting a terrorism risk, and profiting
WASHINGTON — Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he...
Tags: U.S. Department of Defense, Michael Chertoff, U.S. Department of Homeland Security, Science, Finance
-
Human Genome to lay off 97 workers
Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...Tags: Labor Legislation, Job Layoffs, Career and Workplace, Layoffs and Downsizing, Rockville (Bethlehem, Pennsylvania)
-
Human Genome Sciences announces plan to lay off 114
Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...Tags: Labor Legislation, Job Layoffs, Career and Workplace, Layoffs and Downsizing, Rockville (Bethlehem, Pennsylvania)
-
GlaxoSmithKline to acquire Human Genome Sciences
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...Tags: AstraZeneca Plc, Amylin Pharmaceuticals Incorporated, Economy, Business and Finance, Benlysta (drug), Biotechnology Industry
-
GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
Tags: Avandia (drug), Justice System, Corporate Crime, Criminals, Economy, Business and Finance
-
Ripley's opens Odditorium at Harborplace
Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion. Ripley Entertainment Inc. said exhibits at the Inner Harbor...Tags: Justice System, JPMorgan Chase & Co., Inner Harbor, Kevin J. Carey, Science
-
Consolidation wave poised to hit state's health care services, biopharma sectors
Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...Tags: AstraZeneca Plc, Layoffs and Downsizing, Constellation Energy Group, Economy, Business and Finance, Benlysta (drug)
Jun 13, 2013
|Story| Reuters
Jun 2, 2013
|Story| Los Angeles Times
May 30, 2013
|Story| Baltimore Sun
May 22, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
Oct 17, 2012
|Story| Baltimore Sun
Sep 5, 2012
|Story| Baltimore Sun
Jul 16, 2012
|Story| Baltimore Sun
Jul 2, 2012
|Story| Los Angeles Times
Jun 8, 2012
|Story| Baltimore Sun
Apr 21, 2012
|Story| Baltimore Sun
Original site for Human Genome Sciences Inc. topic gallery.